Search Results
Aug 03, 2026, 08:15 ET Why Bank Remediation Falls Short When Institutions Treat Findings in Isolation
As the OCC continues to issue and terminate bank enforcement actions, FFERM founder and CEO Dr. Jeffrey L. Edwards says institutions must look beyond closing individual findings and identify the interconnected risk failures that allowed them to develop.CHARLOTTE,
More news about: FFERM Technologies
Aug 03, 2026, 08:00 ET Triquetra Health Launches BioActive Vitamin B1™--First Complete B1 Activation System with 600mg Research-Matched Dose and Full Cofactor Support
amazon.com/dp/B0G66Y1P5L. Published pharmacokinetic research demonstrates benfotiamine's fat-soluble structure achieves plasma thiamine bioavailability 1,147%
More news about: Triquetra Health LLC
Aug 03, 2026, 08:00 ET Levi & Korsinsky LLP and Wohl & Fruchter LLP Announce Pendency and Proposed Settlement of Class Action Affecting Preferred Stockholders of Cedar Realty Trust, Inc.
C-15-cv-25-000731 (the "Action") is pending in the Court. YOU ARE ALSO NOTIFIED that Plaintiffs Anthony Aquino, Julian Bindler, Leonard B. Linsker, William L. Nist, and The Richard Pfeffer Family Limited Partnership ("Plaintiffs"), on behalf of themselves and the putative Class have reached a settlement ("Settlement")
More news about: Levi & Korsinsky, LLP and Wohl & Fruchter LLP
Aug 03, 2026, 07:45 ET Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with a KRAS G12C mutation and PD-L1 expression ≥ 50%, as determined by FDA approved tests.
More news about: Eli Lilly and Company
Aug 03, 2026, 07:30 ET Keenova Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Manuscript in Translational Andrology and Urology
2003;15(Suppl 5):S91–S92.Stuntz M, Perlaky A, des Vignes F, et al. PLoS One. 2016;11(2):e0150157.DiBenedetti DB, Nguyen D, Zografos L, et al. Adv Urol. 2011; 2011:282503.
More news about: Keenova Therapeutics
Aug 03, 2026, 07:04 ET Delta Development Team's DoW Cold Chain Logistics Solution Assessed "Awardable" in Tradewinds Solutions Marketplace
specializing in battlefield blood logistics and prehospital transfusion solutions. Its integrated ecosystem—including the APRU 6L Portable Blood Refrigerator, Delta ICE 2L Smart Blood Cooler, and BloodCOMM® software platform—helps military and civilian medical teams maintain cold chain compliance and
More news about: Delta Development Team
Aug 03, 2026, 06:00 ET LOEWS CORPORATION REPORTS NET INCOME OF $444 MILLION FOR THE SECOND QUARTER OF 2026
NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Loews Corporation (NYSE: L) today released its second quarter 2026 financial results. Second Quarter 2026 highlights: Loews Corporation reported net income of $444
More news about: Loews Corporation
Aug 03, 2026, 03:00 ET Seegene promuove un approccio completo alla diagnosi delle infezioni dell'apparato riproduttivo attraverso il Global Million Clinical Study (GMCS)
rilevazione simultanea delle infezioni sessualmente trasmissibili (STI) e del papillomavirus umano (HPV) L'annuncio segue il lancio, avvenuto l'8 luglio, del Global Million Clinical Study (GMCS) di Seegene. L'iniziativa punta a produrre evidenze scientifiche a sostegno di nuovi standard globali
More news about: Seegene Inc.
Aug 03, 2026, 01:56 ET IMPACT Therapeutics signe un accord de licence exclusif avec Pharmanovia concernant le sénaparib en Europe, au Moyen-Orient et en Afrique du Nord, ainsi qu'en Australie et en Nouvelle-Zélande
chez les patientes adultes atteintes d'un cancer de l'ovaire avancé en Europe a été officiellement acceptée par l'Agence européenne des médicaments (l'« EMA ») en août 2025, l'autorisation étant attendue pour le second semestre de 2026.En vertu de l'accord de licence relatif au partenariat
More news about: IMPACT Therapeutics
Aug 03, 2026, 01:33 ET TOMY宣佈tomica終極多層停車庫將於2026年9月起在10個亞洲市場上市 首個官方粉絲社群定於10月上線
.jpgTOMICA OWNER'S CLUB：https://cdn.kyodonewsprwire.jp/prwfile/release/M000076/202607212845/_prw_PI7fl_q1L6FEMO.jpegTOMY Company,
More news about: TOMY Company, Ltd.
Aug 02, 2026, 10:01 ET New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
relapsed or refractory DLBCL. Minjuvi is also approved in combination with rituximab and lenalidomide for adult patients with relapsed or refractory FL (2L+ FL). In Australia, Minjuvi® (tafasitamab) is indicated in combination with lenalidomide followed by Minjuvi monotherapy for the treatment
More news about: Specialised Therapeutics
Aug 01, 2026, 09:00 ET Building the Ultimate Gaming Experience, Omniverse Upgrade: Dodge Brings the Viper ACR to Forza Horizon 6 and LEGO Technic
420-horsepower Dodge Charger R/T with the most standard horsepower of any muscle car550-horsepower Dodge Charger Scat Pack, powered by the 3.0L twin-turbo SIXPACK high-output (H.O.) engine - the most powerful Hurricane engine in productionQuickest and most powerful AWD muscle car in the
More news about: Stellantis
Aug 01, 2026, 00:00 ET XPENG Announces Vehicle Delivery Results for July 2026
Company's cumulative deliveries reached a new milestone of more than 1.2 million units worldwide.On July 16, XPENG held its Brand Day and the L03 Global Launch Event in Munich, Germany. The new global model will launch in 65 countries and regions this year, expanding
More news about: XPeng Inc.
Jul 31, 2026, 15:57 ET ПОЛОЖИТЕЛЬНАЯ ОЦЕНКА CHMP ПОДДЕРЖИВАЕТ БОЛЕЕ ШИРОКОЕ ПРИМЕНЕНИЕ ПРЕПАРАТА REPATHA® КОМПАНИИ AMGEN ДЛЯ СНИЖЕНИЯ РИСКА ПЕРВОГО ИНФАРКТА ИЛИ ИНСУЛЬТА
инвесторов)СПИСОК ЛИТЕРАТУРЫMartin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., Commodore-Mensah, Y., Currie, M. E., Elkind, M. S. V., Fan, W., Generoso, G., Gibbs, B. B., Heard, D.
More news about: Amgen
Jul 31, 2026, 12:20 ET KLADNÉ STANOVISKO CHMP PODPORUJE ŠIRŠÍ POUŽITÍ PŘÍPRAVKU REPATHA® SPOLEČNOSTI AMGEN PŘED PRVNÍM INFARKTEM NEBO MOZKOVOU MRTVICÍ
805-447-1746 (investoři)ODKAZYMartin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., Commodore-Mensah, Y., Currie, M. E., Elkind, M. S. V., Fan, W., Generoso, G., Gibbs, B. B., Heard, D.
More news about: Amgen
Jul 31, 2026, 09:00 ET EOS BUILDS ON ITS LIP CARE LEADERSHIP WITH LAUNCH OF DEWY LIP SHINE
more information, please visit www.evolutionofsmooth.com.*NielsenIQ across xAOC L52W in USDA organic lip balm
More news about: eos Products
Jul 31, 2026, 08:37 ET CCTV+ : Heure de Pékin : une journée au rythme de Pékin
PÉKIN, 31 juillet 2026 /PRNewswire/ -- À quoi ressemble vraiment l'« heure de Pékin ?
More news about: CCTV+
Jul 31, 2026, 08:05 ET Life Time's Experience Life Magazine Celebrates 25 Years; Launches Reimagined Website for Convenient Access to Decades of Expert Health and Wellness Content
lives through its more than 195 athletic country clubs across the U.S. and Canada, the complimentary and comprehensive Life Time app featuring its L•AI•C™ AI-powered health companion, and more than 30 iconic athletic events. Serving people ages 90 days to 90+ years, the Life Time ecosystem uniquely delivers
More news about: Life Time, Inc.
Jul 31, 2026, 07:00 ET Enbridge Reports Strong Second Quarter Results, Reaffirms 2026 Guidance and Grows Secured Backlog to $41B
$0.27789Preference Shares, Series LUS$0.36612
More news about: Enbridge Inc.
Jul 31, 2026, 06:51 ET Timken Announces Key Leadership Appointments
multinational footprint, enterprise operations, procurement and supply chain functions, operational excellence initiatives and end-to-end profit and loss (P&L) ownership."This change is designed to enhance execution, speed and accountability to accelerate profitable growth and better serve our customers,"
More news about: The Timken Company
Jul 31, 2026, 06:03 ET ECARX-Backed Chip Maker SiEngine Secures US$200M Equity Financing to Accelerate Vertical Silicon-to-Software SDV Innovation
robotaxi manufacturers.ECARX and SiEngine's unified silicon solutions now support passenger vehicles, commercial fleets, and full-spectrum L2 to L4 intelligent driving use cases, expanding the partnership's total addressable market and unlocking long-term growth opportunities.About ECARX
More news about: ECARX Holdings Inc.
Jul 31, 2026, 04:03 ET IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand
commercialized, following its approval as 1L maintenance therapy for OC "all-comers" in China in January 2025, and is reimbursable for OC 1L "all-comers" since January 1, 2026. Senaparib also delivered the most favorable PFS outcome among PARP1/2 inhibitors (non head-to-head) for 1L maintenance therapy for OC "all-comers"
More news about: IMPACT Therapeutics
Jul 31, 2026, 03:48 ET IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand
commercialized, following its approval as 1L maintenance therapy for OC "all-comers" in China in January 2025, and is reimbursable for OC 1L "all-comers" since January 1, 2026. Senaparib also delivered the most favorable PFS outcome among PARP1/2 inhibitors (non head-to-head) for 1L maintenance therapy for OC "all-comers"
More news about: IMPACT Therapeutics
Jul 30, 2026, 19:50 ET U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
10.1093/ndt/gfw310. Erratum in: Nephrol Dial Transplant. 2021 Jul 23;36(8):1555-1556. doi: 10.1093/ndt/gfaa322.4 Weiner DE, Falzon L, Skoufos L, et al. Efficacy and safety of expanded hemodialysis with the Theranova 400 dialyzer: A randomized controlled trial. Clin J Am Soc Nephrol.
More news about: U.S. Renal Care
Jul 30, 2026, 17:45 ET FAIR, Indiana Take Sanctuary Jurisdiction to Court
removal proceedings."Given the way federal law is written, adequate detention space is crucial for full enforcement of our immigration laws," said Dale L. Wilcox, executive director and general counsel of FAIR. "Merrillville is brazenly trying to hobble that enforcement by blocking ICE from expanding detention
More news about: Federation for American Immigration Reform (FAIR)